Patient Buzz Series: Dermatology Post-Quarantine
EPI Health has graciously supported the COVID-19 News and Resource Center.
As states begin easing restrictions, this month’s Patient Buzz includes several articles on how to care for the skin post-quarantine. Are mask-off injectable treatments safe for patients and providers? What skin, hair and nail concerns need an in-person visit, and what can be addressed virtually? How will COVID-19 for …
EPI Health has graciously supported the COVID-19 News and Resource Center.
As states begin easing restrictions, this month’s Patient Buzz includes several articles on how to care for the skin post-quarantine. Are mask-off injectable treatments safe for patients and providers? What skin, hair and nail concerns need an in-person visit, and what can be addressed virtually? How will COVID-19 for … Continue reading "Patient Buzz Series: Dermatology Post-Quarantine"
Melanoma remains the most common cause of death among skin cancers. Over the past decade, major leaps have been made in treating advanced melanoma, resulting in unprecedented improvement in survival. Nevertheless, a large room for improvement is still ahead. In his presentation Therapeutic Updates in Melanoma: IO for Earlier Stage Disease presented at the 2020 ODAC Dermatology, Aesthetic and Sur … 
This patient presents for Mohs surgery. What is the deepest layer that you can undermine in this area?
A. Epidermis
B. Dermis
C. Subcutaneous fat
D. Superficial muscular aponeurotic system (SMAS)
E. Muscle
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference interviewed Dr. Adam Friedman, Professor, Interim Chair of Dermatology, and Residency Program Director at George Washington University, on some of the common misconceptions and controversies surrounding photoprotection.
With ample evidence today that shows that sunscreen both reduces the incidence of me … 
Have you ever come across a patient with a skin cancer that you are not 100% sure should be treated with Mohs surgery or an alternative modality? Or a patient who comes back for a follow-up after skin cancer surgery with an undesirable scar and you wonder if you should have opted for a less invasive option? I certainly have. Some of these nagging questions were answered by a thoughtful, case-based … 